Global histone H3 lysine 27 (H3K27) methylation levels and their prognostic relevance in renal cell carcinoma

BJU International

Volumn 109, Issue 3, 2012, Pages 459-465

  Rogenhofer, Sebastian ^a   Kahl, Philip ^b   Mertens, Claudia ^a   Hauser, Stefan ^a   Hartmann, Wolfgang ^b   Büttner, Reinhard ^b   Müller, Stefan C ^a   Von Ruecker, Alexander ^b   Ellinger, Jörg ^a  

^a Department of Urology ^*  (Germany)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

H3K27; histone; methylation; prognosis; renal cell carcinoma

Indexed keywords

HISTONE H3; LYSINE;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER RELAPSE; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CLEAR CELL CARCINOMA; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; HISTONE METHYLATION; HISTONE MODIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY ADENOMA; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; ONCOCYTOMA; PAPILLARY CARCINOMA; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; TISSUE MICROARRAY; TISSUE SECTION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; JUMONJI DOMAIN-CONTAINING HISTONE DEMETHYLASES; KAPLAN-MEIER ESTIMATE; KIDNEY NEOPLASMS; LYMPHATIC METASTASIS; MALE; METHYLATION; MIDDLE AGED; PROGNOSIS; TISSUE ARRAY ANALYSIS;

EID: 84855942931     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2011.10278.x     Document Type: Article

References (25)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ,. Cancer statistics, 2009. CA Cancer J Clin 2009; 59: 225-49
2. Patard JJ, Leray E, Rioux-Leclercq N, et al,. Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience. J Clin Oncol 2005; 23: 2763-71 (Pubitemid 46179466)
3. Esteller M,. Epigenetics in cancer. N Engl J Med 2008; 358: 1148-59
4. Kawamoto K, Hirata H, Kikuno N, Tanaka Y, Nakagawa M, Dahiya R,. DNA methylation and histone modifications cause silencing of Wnt antagonist gene in human renal cell carcinoma cell lines. Int J Cancer 2008; 123: 535-42 (Pubitemid 351898410)
5. Gonzalgo ML, Yegnasubramanian S, Yan G, et al,. Molecular profiling and classification of sporadic renal cell carcinoma by quantitative methylation analysis. Clin Cancer Res 2004; 10: 7276-83 (Pubitemid 39487715)
6. Kouzarides T,. Chromatin modifications and their function. Cell 2007; 128: 693-705 (Pubitemid 46273577)
7. Barski A, Cuddapah S, Cui K, et al,. High-resolution profiling of histone methylations in the human genome. Cell 2007; 131: 823-37 (Pubitemid 46802390)
8. Orr JA, Hamilton PW,. Histone acetylation and chromatin pattern in cancer. A review. Anal Quant Cytol Histol 2007; 29: 17-31 (Pubitemid 46333518)
9. Seligson DB, Horvath S, Shi T, et al,. Global histone modification patterns predict risk of prostate cancer recurrence. Nature 2005; 435: 1262-6 (Pubitemid 40943093)
10. Ellinger J, Kahl P, von der Gathen J, et al,. Global levels of histone modifications predict prostate cancer recurrence. Prostate 2009; 70: 61-9
11. Barlesi F, Giaccone G, Gallegos-Ruiz MI, et al,. Global histone modifications predict prognosis of resected non small-cell lung cancer. J Clin Oncol 2007; 25: 4358-64 (Pubitemid 350013840)
12. Barbisan F, Mazzucchelli R, Santinelli A, et al,. Immunohistochemical evaluation of global DNA methylation and histone acetylation in papillary urothelial neoplasm of low malignant potential. Int J Immunopathol Pharmacol 2008; 21: 615-23
13. Seligson DB, Horvath S, McBrian MA, et al,. Global levels of histone modifications predict prognosis in different cancers. Am J Pathol 2009; 174: 1619-28
14. Kanao K, Mikami S, Mizuno R, Shinojima T, Murai M, Oya M,. Decreased acetylation of histone H3 in renal cell carcinoma: a potential target of histone deacetylase inhibitors. J Urol 2008; 180: 1131-6
15. Minardi D, Lucarini G, Filosa A, et al. Prognostic role of global DNA-methylation and histone acetylation in PT1a clear cell renal carcinoma in partial nephrectomy specimens. J Cell Mol Med 2008; 13: 215-21
16. Ellinger J, Kahl P, Mertens C, et al,. Prognostic relevance of global histone H3 lysine 4 (H3K4) methylation in renal cancer carcinoma. Int J Cancer 2010; 127: 2360-6
17. Remmele W, Stegner HE,. [Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue]. Pathologe 1987; 8: 138-40
18. Mosashvilli D, Kahl P, Mertens C, et al. Global histone acetylation levels: prognostic relevance in patients with renal cell carcinoma. Cancer Sci 2010; 101: 2664-9
19. Wagener N, Holland D, Bulkescher J, et al,. The enhancer of zeste homolog 2 gene contributes to cell proliferation and apoptosis resistance in renal cell carcinoma cells. Int J Cancer 2008; 123: 1545-50
20. Johnson AB, Denko N, Barton MC,. Hypoxia induces a novel signature of chromatin modifications and global repression of transcription. Mutat Res 2008; 640: 174-9
21. Pollard PJ, Loenarz C, Mole DR, et al,. Regulation of Jumonji-domain-containing histone demethylases by hypoxia-inducible factor (HIF)-1alpha. Biochem J 2008; 416: 387-94
22. Shi Y,. Histone lysine demethylases: emerging roles in development, physiology and disease. Nat Rev Genet 2007; 8: 829-33 (Pubitemid 47609092)
23. Jacob Y, Feng S, LeBlanc CA, et al. ATXR5 and ATXR6 are H3K27 monomethyltransferases required for chromatin structure and gene silencing. Nat Struct Mol Biol 2009; 16: 763-8
24. Fraga MF, Ballestar E, Villar-Garea A, et al,. Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer. Nat Genet 2005; 37: 391-400
25. Eden A, Gaudet F, Waghmare A, Jaenisch R,. Chromosomal instability and tumors promoted by DNA hypomethylation. Science 2003; 300: 455 (Pubitemid 36444319)